Talk:Transcription activator-like effector nuclease
Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent. |
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
note
[edit]This article could be improved by adding a section on the history of the discovery of TALENs. Biolprof (talk) 21:43, 22 January 2014 (UTC)
Wiki Education assignment: CHEM 378 - Biochemistry Lab
[edit]This article was the subject of a Wiki Education Foundation-supported course assignment, between 31 January 2022 and 22 May 2022. Further details are available on the course page. Student editor(s): Saucyscience (article contribs).
Mention of the role of AvrBs3 in the history of understanding TALEN?
[edit]Or is that too detailed? The relevant paper is already submitted as a source. Patwis (talk) 11:15, 25 May 2022 (UTC)
Please translate this sentence to proper English (and define PAM sites)
[edit]"gRNAs have occasionally limitations regarding feasibility due to lack of PAM sites in the target sequence and even though they can be cheaply produced, the current development lead to a remarkable decrease of cost for TALENs, so that they are in a similar price and time range like CRISPR based genome editing" 162.249.205.250 (talk) 22:38, 24 April 2023 (UTC)